CA
NZ
UK
AU
IND
US
Prothena (NASDAQ: PRTA) reported earnings per share of $‑0.32 for the quarter ended June 30, outpacing the $‑0.40 consensus and shrinking the quarterly net loss to $18.6 million. The result highlights a dramatic improvement from the $125.8 million loss recorded in the same quarter …
Pulse Biosciences, Inc. (NASDAQ: PLSE) has initiated a significant sales agreement that enables it to distribute shares worth up to $75 million. This agreement enhances the company's financial flexibility as it can tap the equity market to fund operations and growth initiatives. Optimal funding …
Oscar Health's stock is experiencing a notable decline as investor anxieties about its second-half performance intensify. Key concerns include heightened competition and the uncertainty surrounding profitability amidst evolving market conditions. This growing caution reflects a broader sentiment among healthcare investors who are increasingly wary …
Outset Medical (NASDAQ: OM) delivered Q2 revenue of $31.6 million, edging up 1 % from the same quarter a year earlier and climbing 14 % sequentially. Gross margin widened to 42 %, an improvement of over 400 basis points versus the prior year. Earnings …
Although this figure represents a decline of 12.3% year-over-year, it indicates resilience amid challenging market conditions. Revenue for the quarter ended June 27, 2026, fell 3.2% to $1.023 billion, down from $1.056 billion a year earlier. Market response to this earnings beat has been …
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported a net loss of $4.1 million for the quarter ending June 30, 2026, marking a substantial increase from a $2.2 million loss in the same period last year. This loss highlights ongoing financial pressures as the company expands …
Prestige Consumer Healthcare Inc. (NYSE: PBH) reported first-quarter revenues of $265.7 million for fiscal 2027, reflecting a year-over-year increase of 6.5%. The growth was aided by a 3.2% rise in organic sales, exceeding market expectations. The company’s adjusted diluted earnings per share stood at …
Prestige Consumer Healthcare Inc. (NYSE: PBH) reported first-quarter revenues of $265.7 million for fiscal 2027, reflecting a year-over-year increase of 6.5%. The growth was aided by a 3.2% rise in organic sales, exceeding market expectations. The company’s adjusted diluted earnings per share stood at …
Progyny, Inc. reported a record revenue of $350.5 million for the second quarter of 2026, marking a 5.3% increase from the previous year’s $332.9 million and exceeding analyst expectations. The earnings per share (EPS) of $0.55 also outperformed the consensus estimate of $0.34, highlighting …
Maravai LifeSciences (NASDAQ: MRVI) announced that its second‑quarter earnings per share stayed in negative territory yet surpassed analyst forecasts, while total revenue climbed 9% year‑over‑year to $51.4 million. This combination of a earnings beat and top‑line growth signals a potential shift in the company’s …
Please wait processing your request...